{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that Parkinson's disease (PD)-associated genomic deletions and the L166P mutation lead to loss of the cytoprotective DJ-1 protein.",
          "judgment": "Yes",
          "reasoning": "The paper establishes a clear link between DJ-1 loss-of-function and PD, indicating a disease mechanism related to DJ-1's protective function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses protein expression assays, protein interaction studies, and cell viability assays to determine the effect of the M26I mutation on DJ-1 function. These assays directly assess the functional consequences of the mutation, relevant to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assays used are relevant to the disease mechanism by probing the functional consequences of DJ-1 mutation on protein expression, interaction, and cell survival.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper states experiments were performed using knockout mouse embryonic fibroblasts and measures suppression of apoptosis signal-regulating kinase 1 (ASK1) and cytotoxicity, implying the use of controls and replicates in experimental design.",
          "judgment": "Yes",
          "reasoning": "The mention of knockout mouse embryonic fibroblasts suggests the use of a null control. Assessing ASK1 suppression and cytotoxicity indicates replication within the experimental design."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study compares the M26I mutation to other DJ-1 methionine and cysteine mutants, as well as wild-type DJ-1, allowing for comparisons and control for functional effects.",
          "judgment": "Yes",
          "reasoning": "The use of other DJ-1 mutants serves as variant controls, facilitating comparison and assessing the specific impact of the M26I mutation."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper does not report OddsPath or direct statistical analysis correlating pathogenicity for the functional data.",
          "judgment": "No",
          "reasoning": "No OddsPath calculation was performed or reported in the study."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The M26I mutation reduces DJ-1 expression and leads to constitutive ASK1 binding, failing to suppress ASK1 activity and protect against cell death. While a limited number of variants were tested in comparison, the functional data support a pathogenic role for this variant."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "A",
          "position": "106"
        },
        "variant_string_id": "DJ-1 C106A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that Parkinson's disease (PD)-associated genomic deletions and the L166P mutation lead to loss of the cytoprotective DJ-1 protein.",
          "judgment": "Yes",
          "reasoning": "The paper establishes a clear link between DJ-1 loss-of-function and PD, indicating a disease mechanism related to DJ-1's protective function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses protein interaction studies and cell viability assays to determine the effect of the C106A mutation on DJ-1 function.",
          "judgment": "Yes",
          "reasoning": "The assays used are relevant to the disease mechanism by probing the impact of the mutation on protein interaction and cell survival."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper states experiments were performed using knockout mouse embryonic fibroblasts and measures suppression of apoptosis signal-regulating kinase 1 (ASK1) and cytotoxicity, implying the use of controls and replicates in experimental design.",
          "judgment": "Yes",
          "reasoning": "The mention of knockout mouse embryonic fibroblasts suggests the use of a null control. Assessing ASK1 suppression and cytotoxicity indicates replication within the experimental design."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study compares the C106A mutation to other DJ-1 methionine and cysteine mutants, as well as wild-type DJ-1, allowing for comparisons and control for functional effects.",
          "judgment": "Yes",
          "reasoning": "The use of other DJ-1 mutants serves as variant controls, facilitating comparison and assessing the specific impact of the C106A mutation."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper does not report OddsPath or direct statistical analysis correlating pathogenicity for the functional data.",
          "judgment": "No",
          "reasoning": "No OddsPath calculation was performed or reported in the study."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The C106A mutation abolishes binding to ASK1 and eliminates cytoprotection. The functional data support a pathogenic role for this variant, but a limited number of variants were tested."
    }
  ]
}